TNDM
Tandem Diabetes Care·NASDAQ
--
--(--)
--
--(--)
6.04 / 10
Outperform
Fund flow is strong (7.92/10) with positive inflows across all investor sizes. Analyst opinions are split: one Strong Buy, one Buy, one Neutral, yielding a modest sentiment score of 6.04 and mixed confidence.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
33%
Buy
33%
Hold
0%
Sell
0%
Strong Sell
0%
Matthew Oliver O'BrienBuy
Date2026-03-17
InstitutionPiper Sandler
Times predicted4
Historical Win Rate25.0%
Patrick WoodNeutral
Richard NewitterStrong Buy
Is money flowing into or out of TNDM?
- TNDM holds a Bearish analyst rating, with 33% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 6.04/10 (Outperform).
